CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Eargo Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Eargo Inc
2665 North First Street, Suite 300
Phone: (650) 351-7700p:650 351-7700 SAN JOSE, CA  95134  United States Fax: (909) 592-2228f:909 592-2228
This company ceased filing statements with the SEC on 2/26/2024.
On 11/29/2022, the Company was acquired by Patient Square Capital.
This company is no longer actively traded on any major stock exchange.
Business Summary
Eargo, Inc. is a medical device company. The Company is engaged in developing products to improve the quality of life of people with hearing loss. Its Eargo hearing aids are virtually invisible, rechargeable, completely in-the-canal devices indicated to compensate for mild to moderate hearing loss. Its in-the-canal devices feature quality audio, which are designed to provide up to 16 hours of battery life and feature its soft flexible medical-grade silicon tips. It is marketing various versions of hearing aids, the Eargo Max, the Eargo Neo HiFi, Eargo 5, Eargo 6 and Eargo 7. The Company markets and sells its hearing aids primarily in a direct-to-consumer format, engaging consumers through a mix of digital and traditional marketing as well as select commercial partnership, and omni-channel (including retail). Its devices are self-fitting hearing aids and are adjusted by the user to meet the user’s hearing needs, without pre-programming or a hearing test from a hearing care professional.
(Source: 10-K)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/202312/31/2022YesYes--Yes

Industries
SIC Code Description
3842 Orthopedic, prosthetic, and surgical appliances and supplies
3845 Electromedical and electrotherapeutic apparatus

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Non-Executive Independent Chairman of the Board Donald J.Spence 69 12/7/2022 12/7/2022
Interim Chief Executive Officer, Chief Operating Officer WilliamBrownie 56 6/30/2023 4/1/2019
Chief Financial Officer, Chief Accounting Officer MarkThorpe 55 1/5/2024 1/16/2022
4 additional Officers and Directors records available in full report.

Business Names
Business Name
EAR
Eargo Hearing, Inc.
Eargo Screening, LLC

General Information
Number of Employees: 243 (As of 12/31/2022)
Outstanding Shares: 20,772,485 (As of 1/12/2024)
Shareholders: 67
Stock Exchange: NASD
Federal Tax Id: 273879804
Fax Number: (909) 592-2228


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Tuesday, April 23, 2024